Revolution Medicines, Inc. (RVMD) has a consensus analyst rating of Buy, based on 20 analysts covering the stock. Of those, 19 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for RVMD is $124.36, representing a -15.4% downside from the current price of $147.01. Price targets range from a low of $73.00 to a high of $170.00.
